SEC-sourced researchBeta
PBSV
Pharma-Bio Serv, Inc.
Company comparison ↗
Data passport
- CIK
- 0001304161
- Exchange
- OTC
- Business activity
- — · SIC 8742
- Financial inputs
- 6/6
- Filing date
- Sep 14, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| October 2024 | 9,509,279.0000 | Jan 29, 2026 |
| October 2025 | 9,001,096.0000 | Jan 29, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| October 2025 | 9,001,096.0000 | -100,463.0000 | -214,886.0000 | 13,653,046.0000 | 1,738,799.0000 | Jan 29, 2026 |
| October 2024 | 9,509,279.0000 | -777,619.0000 | -566,701.0000 | 16,292,230.0000 | 2,576,903.0000 | Jan 29, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $9M | October 2025 | Jan 29, 2026 | 10-K |
| Previous period revenueRevenues | $9.51M | October 2024 | Jan 29, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$100.46K | October 2025 | Jan 29, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$214.89K | October 2025 | Jan 29, 2026 | 10-K |
| Total assetsAssets | $13.65M | October 2025 | Jan 29, 2026 | 10-K |
| Total liabilitiesLiabilities | $1.74M | October 2025 | Jan 29, 2026 | 10-K |